Dominika Kos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dominika Kos has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alois Cizek
Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic
2 shared publications - Josef Jampilek
Department of Chemical Biology, Faculty of Science, Palacky University Olomouc, Slechtitelu 27, 779 00 Olomouc, Czech Republic
2 shared publications - Veronika Vojáčková
Department of Experimental Biology, Faculty of Science, Palacky University Olomouc, Slechtitelu 27, 779 00 Olomouc, Czech Republic
2 shared publications - Vladimír Kryštof
Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 77900 Olomouc, Czech Republic
2 shared publications - Branislav Horváth
NMR Laboratory, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, 832 32 Bratislava, Slovakia
1 shared publication - Emil Švajdlenka
Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-820 18 Bratislava 218, P.O. BOX 90 Bratislava, Slovakia
1 shared publication
Latest Publications
- Open Access
- 11 June 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 212, 107167
Preparation and biological activity of isoperrottetin A and its phosphonium salts derivatives
- 11 June 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 212, 107167
Open AccessPreparation and biological activity of isoperrottetin A and its phosphonium salts derivatives
- 19 November 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 154, 107957
Trifluoromethylcinnamanilides – Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum
- 19 November 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 154, 107957
Trifluoromethylcinnamanilides – Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum